BioCentury
ARTICLE | Clinical News

KVD001: Phase I started

September 15, 2014 7:00 AM UTC

KalVista began an open-label, U.S. Phase I trial to evaluate single ascending doses of intravitreal KVD001 in about 17 patients. ...